Kura Oncology, Inc. · NASDAQ:KURA
Montanova Capital, LLC reported a 6.70% stake in Kura Oncology, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 13, 2025
Montanova Capital, LLC reported a 6.70% stake in Kura Oncology, Inc., 5,198,189 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 5,198,189
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.70% | 5,198,189 |
| Averill Master Fund, Ltd. | 5.90% | 4,592,673 |
| Aaron Cowen | 6.70% | 5,198,189 |
Source
Related
- Kura Oncology, Inc.
- Montanova Capital, LLC
- Kura Oncology, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · May 2, 2025
- Form 4 · Ford Kathleen · Sep 29, 2026
- Form 4 · Leoni Mollie · Sep 29, 2026
- Form 4 · Powl Brian T. · Sep 29, 2026
- Form 4 · Bair Teresa Brophy · Sep 29, 2026
- Form 4 · Doyle Thomas James · Sep 29, 2026